ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

TYO:4886 Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	69,088	65,350	62,863	33,620	35,672	41,729
Market Cap Growth	25.56%	3.96%	86.98%	-5.75%	-14.52%	34.20%
Enterprise Value	82,226	62,609	52,614	28,088	28,719	47,720
Last Close Price	2433.00	2277.74	2141.35	1124.26	1177.74	1338.61
PE Ratio	14.07	12.81	8.33	7.93	8.32	15.38
PS Ratio	1.01	1.02	1.00	0.56	0.63	0.76
PB Ratio	0.92	0.94	1.01	0.62	0.73	0.94
P/TBV Ratio	1.15	1.12	1.07	0.67	0.84	1.28
P/FCF Ratio	-	-	378.69	11.63	15.76	7.68
P/OCF Ratio	-	26.30	42.30	10.03	12.55	6.38
EV/Sales Ratio	1.20	0.98	0.84	0.47	0.51	0.87
EV/EBITDA Ratio	12.60	8.26	5.74	3.41	3.74	6.90
EV/EBIT Ratio	17.91	11.74	8.09	5.50	5.99	13.22
EV/FCF Ratio	-	-	316.95	9.72	12.69	8.78
Debt / Equity Ratio	0.18	0.16	0.15	0.23	0.29	0.37
Debt / EBITDA Ratio	-	1.44	1.04	1.53	1.83	2.37
Debt / FCF Ratio	-	-	57.14	4.37	6.21	3.02
Asset Turnover	0.67	0.67	0.71	0.71	0.68	0.68
Inventory Turnover	1.37	1.40	1.69	1.95	2.06	2.10
Quick Ratio	1.06	1.15	1.37	1.88	1.97	1.41
Current Ratio	2.40	2.54	2.34	3.05	3.10	2.39
Return on Equity (ROE)	7.19%	7.78%	12.96%	8.20%	9.19%	6.30%
Return on Assets (ROA)	2.91%	3.48%	4.57%	3.75%	3.61%	2.77%
Return on Invested Capital (ROIC)	5.95%	7.14%	9.62%	8.50%	6.94%	5.42%
Return on Capital Employed (ROCE)	5.40%	6.90%	9.70%	7.40%	7.10%	5.50%
Earnings Yield	7.10%	7.81%	12.00%	12.61%	12.03%	6.50%
FCF Yield	-	-0.73%	0.26%	8.60%	6.34%	13.03%
Dividend Yield	2.27%	2.42%	1.87%	1.42%	1.27%	-
Payout Ratio	-	25.00%	10.50%	10.66%	9.28%	17.84%
Buyback Yield / Dilution	-0.11%	-0.12%	-0.26%	0.46%	-0.06%	-0.23%
Total Shareholder Return	2.15%	2.30%	1.61%	1.88%	1.21%	-0.23%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.